We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+5.78%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.95B
AUM Growth
-$232M
(-4.5%)
Cap. Flow
-$467M
Cap. Flow
% of AUM
-9.44%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
1,100
New
153
Increased
294
Reduced
399
Closed
191
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$28.6M |
| 2 |
Intuit
INTU
|
+$27.6M |
| 3 |
Electronic Arts
EA
|
+$23.2M |
| 4 |
Qualcomm
QCOM
|
+$22.5M |
| 5 |
Chevron
CVX
|
+$19.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$41.2M |
| 2 |
Apple
AAPL
|
+$38.4M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$37.2M |
| 4 |
Advanced Micro Devices
AMD
|
+$26.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$25.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.09% |
| 2 | Financials | 17.69% |
| 3 | Healthcare | 13.21% |
| 4 | Industrials | 12.31% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNTA
526
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.19M | 0.02% |
+89,031
| New | +$1.39M |
|
527
ABM Industries
ABM
$2.8B
| $1.19M | 0.02% |
27,216
| – | – |
|
528
Azenta
AZTA
$1.26B
| $1.18M | 0.02% |
52,526
-200
| -0.4% | -$3.97K |
|
|
CTRL
529
DELISTED
Control4 Corporation
CTRL
| $1.17M | 0.02% |
74,110
-3,610
| -5% | -$48.4K |
|
530
Marcus & Millichap
MMI
$1.15B
| $1.17M | 0.02% |
+47,554
| New | +$1.23M |
|
531
Rush Enterprises Class A
RUSHA
$5.95B
| $1.16M | 0.02% |
+78,964
| New | +$1.17M |
|
532
TriCo Bancshares
TCBK
$1.85B
| $1.16M | 0.02% |
32,580
| – | – |
|
533
Heritage Insurance Holdings
HRTG
$842M
| $1.16M | 0.02% |
90,581
-1,300
| -1% | -$18.7K |
|
|
XENT
534
DELISTED
Intersect ENT, Inc
XENT
| $1.15M | 0.02% |
66,936
-53,093
| -44% | -$744K |
|
|
TGH
535
DELISTED
Textainer Group Holdings limited
TGH
| $1.13M | 0.02% |
73,710
+23,241
| +46% | +$317K |
|
536
Modine Manufacturing
MOD
$12.8B
| $1.12M | 0.02% |
91,954
-1,100
| -1% | -$13.7K |
|
|
MOBL
537
DELISTED
MobileIron, Inc.
MOBL
| $1.12M | 0.02% |
257,006
+68,305
| +36% | +$302K |
|
|
CUTR
538
DELISTED
Cutera, Inc.
CUTR
| $1.12M | 0.02% |
53,965
+15,540
| +40% | +$307K |
|
|
IVC
539
DELISTED
Invacare Corporation
IVC
| $1.12M | 0.02% |
93,788
-157,829
| -63% | -$1.89M |
|
540
TriNet
TNET
$2.84B
| $1.09M | 0.02% |
37,700
+2,500
| +7% | +$67K |
|
541
Norwegian Cruise Line
NCLH
$8.89B
| $1.07M | 0.02% |
21,040
-85,670
| -80% | -$4.16M |
|
|
NP
542
DELISTED
Neenah, Inc. Common Stock
NP
| $1.07M | 0.02% |
14,270
| – | – |
|
543
Biglari Holdings Class B
BH
$1.2B
| $1.05M | 0.02% |
3,654
+1,480
| +68% | +$433K |
|
544
Kohl's
KSS
$2.03B
| $1.05M | 0.02% |
26,400
+4,420
| +20% | +$180K |
|
|
KND
545
DELISTED
Kindred Healthcare
KND
| $1.04M | 0.02% |
125,167
-97,200
| -44% | -$761K |
|
546
MillerKnoll
MLKN
$1.5B
| $1.04M | 0.02% |
+33,050
| New | +$1.02M |
|
547
Regency Centers
REG
$15B
| $1.04M | 0.02% |
15,700
-77,095
| -83% | -$5.28M |
|
548
Assembly Biosciences
ASMB
$506M
| $1.04M | 0.02% |
3,397
| – | – |
|
|
TTPH
549
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $1.04M | 0.02% |
+5,650
| New | +$633K |
|
550
Employers Holdings
EIG
$908M
| $1.03M | 0.02% |
27,190
+430
| +2% | +$16.2K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2017 Portfolio in Review
As of Q1 2017, Jacobs Levy Equity Management held 1,100 positions worth $4.95B, down 4.5% from $5.18B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $467M in Q1 2017, closing 191 positions and reducing 399 holdings. Its most notable exit was VMware, Inc, an estimated $22.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Intuit worth $26.7M.
- Jacobs Levy Equity Management's largest Q1 2017 buy was Intuit: 229,923 shares worth $26.7M.
- Jacobs Levy Equity Management added most to Celgene Corp in Q1 2017, an estimated $28.6M increase.
- Jacobs Levy Equity Management's biggest Q1 2017 reduction was Amgen, cutting an estimated $41.2M.
- Jacobs Levy Equity Management fully exited VMware, Inc in Q1 2017, selling an estimated $22.6M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $4.95B portfolio in Q1 2017.
- Jacobs Levy Equity Management opened 153 new positions and closed 191 in Q1 2017.
- Jacobs Levy Equity Management's portfolio value fell 4.5% quarter-over-quarter to $4.95B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2017, filed 15 May 2017.